Blosozumab

blosozumab · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Blosozumab, covering 2019-01-22 to 2019-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women [Phase 1]